Featured Courses
Severe Hypertriglyceridaemia: Defining the Disease and Its Management
- 1.00
Published:
Learning objectives
- Recall the mechanisms that make TGs a risk factor for atherosclerosis
- Review how elevated FCS is a major risk factor for pancreatitis
- Discuss the current clinical evidence of TG-lowering therapies in different disease states
Targeting Residual Inflammatory Risk: The Future of Cardiovascular Prevention
- 1.00
Published:
Learning objectives
- Define residual inflammatory risk (RIR) and explain why cardiovascular events continue to occur in patients despite optimal lipid-lowering and antihypertensive therapies
- Describe the pathophysiological role of inflammation in atherosclerosis, myocardial infarction, heart failure and chronic kidney disease
- Identify patients at increased cardiovascular risk due to elevated inflammatory markers, particularly high-sensitivity C-reactive protein (hsCRP)
- Interpret the clinical significance of hsCRP and other inflammatory biomarkers in primary and secondary prevention settings, in alignment with current evidence and guideline recommendations
- Assess clinician practices, barriers and strategies for integrating inflammatory risk assessment and management
- Apply key takeaways to inform future risk assessment and treatment decisions in patients with or at risk for cardiovascular disease
Translating Aortic Stenosis Guidelines Into Practice: Evidence-Based Decisions for the Heart Team
- 1.00
Published:
Learning objectives
- Recall recent guideline recommendations for the management of aortic stenosis
- Summarise the evidence supporting TAVI across the sub-groups of aortic stenosis, age and surgical risk
- Develop an expert guided approach to patient selection and referral for TAVI
- Adopt an evidence-based approach for the lifetime management of younger patients with aortic stenosis
Revolutionising Thrombosis Treatment in ACS, SSP and AF
- 1.00
Published:
Learning objectives
- Discuss the unmet needs in thrombosis management, MACE burden after ACS, stroke in AF and secondary stroke prevalence and consequences
- Evaluate the current standard of care for the treatment of ACS, SSP and AF and its limitations
- Review guidelines and critique current prescribing practices and the implications of inadequate treatment
- Explain the different strategies for targeting FXI and how FXI inhibition mechanisms differentiate from traditional anticoagulation therapies
- Identify emerging anticoagulant strategies and describe the efficacy and safety data from Phase 2 FXI inhibitor clinical trials as well as ongoing Phase 3 trials and potential place in therapy for ACS, AF and SSP
- Apply evidence-based anticoagulation strategies by optimising treatment decisions and addressing patient-specific risk factors
The Rise of CVRM Medicine: Managing Common Co-morbidities as One
- 3.00
Published:
Learning objectives
- Describe the link between T2DM, CKD and ASCVD
- State the importance of early and effective intervention in managing CVRM disease progression
- List the guideline directed therapeutic targets in CVRM disease
- Select appropriate patients for holistic CVRM management
- Recall trial data for novel therapeutic agents that carry benefit for CVRM outcomes
- Develop a holistic management strategy for CVRM disease with an evidence-based impact on clinical outcomes
Managing Hypertension in CVD: How Low Can We Go?
- 1.00
Published:
Learning objectives
- Describe the link between CVD and hypertension
- Classify hypertension patients according to their cardiovascular risk
- Recall recent guideline-directed and evidence-based strategies for managing very high CVD risk patients
- Apply guideline-directed and evidence-based management strategies to a case study
- Use expert guidance to adopt optimal multidisciplinary antihypertensive management strategies in patients with very high cardiovascular risk
Management of Degenerative MR With TEER: An Evidence-based Guide
- 0.75
Published:
Learning objectives
- Identify suitable patients for transcatheter repair over other treatments
- Recall long-term clinical outcomes for TEER in patients with DMR
- Select TEER devices based on design features and clinical data
- Review TEER implantation techniques
TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management
- 1.00
Published:
Learning objectives
- Recall the critical steps in lesion preparation and on post dilation to optimise valve implantation when needed
- Recognise the technical considerations in precise valve positioning and deployment for larger annuli patients
- Explore the long-term implications of index procedure optimisation on patient management and outcomes
- Engage with an expert operator through a live case demonstration and interactive discussion
Available Courses
Severe Hypertriglyceridaemia: Defining the Disease and Its Management
- 1.00
Published:
Learning objectives
- Recall the mechanisms that make TGs a risk factor for atherosclerosis
- Review how elevated FCS is a major risk factor for pancreatitis
- Discuss the current clinical evidence of TG-lowering therapies in different disease states
Targeting Residual Inflammatory Risk: The Future of Cardiovascular Prevention
- 1.00
Published:
Learning objectives
- Define residual inflammatory risk (RIR) and explain why cardiovascular events continue to occur in patients despite optimal lipid-lowering and antihypertensive therapies
- Describe the pathophysiological role of inflammation in atherosclerosis, myocardial infarction, heart failure and chronic kidney disease
- Identify patients at increased cardiovascular risk due to elevated inflammatory markers, particularly high-sensitivity C-reactive protein (hsCRP)
- Interpret the clinical significance of hsCRP and other inflammatory biomarkers in primary and secondary prevention settings, in alignment with current evidence and guideline recommendations
- Assess clinician practices, barriers and strategies for integrating inflammatory risk assessment and management
- Apply key takeaways to inform future risk assessment and treatment decisions in patients with or at risk for cardiovascular disease
TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management
- 1.00
Published:
Learning objectives
- Recall the critical steps in lesion preparation and on post dilation to optimise valve implantation when needed
- Recognise the technical considerations in precise valve positioning and deployment for larger annuli patients
- Explore the long-term implications of index procedure optimisation on patient management and outcomes
- Engage with an expert operator through a live case demonstration and interactive discussion
TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?
- 1.00
Published:
Learning objectives
- Evaluate the factors influencing coronary access in different valve designs
- Formulate strategies to optimise coronary access based on valve characteristics
- Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
- Learn the step-by-step process for achieving optimum implant depth during TAVI
- Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
The Rise of CVRM Medicine: Managing Common Co-morbidities as One
- 3.00
Published:
Learning objectives
- Describe the link between T2DM, CKD and ASCVD
- State the importance of early and effective intervention in managing CVRM disease progression
- List the guideline directed therapeutic targets in CVRM disease
- Select appropriate patients for holistic CVRM management
- Recall trial data for novel therapeutic agents that carry benefit for CVRM outcomes
- Develop a holistic management strategy for CVRM disease with an evidence-based impact on clinical outcomes
TIO 2022 - Session 3.3: Keynote & Controversies: Live Cases And Discussion
- 1.00
Published:
Learning objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
Translating Aortic Stenosis Guidelines Into Practice: Evidence-Based Decisions for the Heart Team
- 1.00
Published:
Learning objectives
- Recall recent guideline recommendations for the management of aortic stenosis
- Summarise the evidence supporting TAVI across the sub-groups of aortic stenosis, age and surgical risk
- Develop an expert guided approach to patient selection and referral for TAVI
- Adopt an evidence-based approach for the lifetime management of younger patients with aortic stenosis
Unravelling the Pathways to Early Intervention in ATTR-CM
- 1.00
Published:
Learning objectives
- Review the binding affinity for current stabilising agents
- Recall the trajectory of disease progression in ATTR-CM
- Discuss future options for individuals who progress on treatment
Most Recent
Severe Hypertriglyceridaemia: Defining the Disease and Its Management
- 1.00
Published:
Learning objectives
- Recall the mechanisms that make TGs a risk factor for atherosclerosis
- Review how elevated FCS is a major risk factor for pancreatitis
- Discuss the current clinical evidence of TG-lowering therapies in different disease states